G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/68 (2006.01)
Patent
CA 2733964
The present invention comprises the use of WNT1 as a biomarker in the monitoring, prognosis and /or in the diagnosis of chronic nephropathies. It provides in vitro prognostic and diagnostic methods and kits for its implementation. The present invention also comprises the use of WNT1 in screening active ingredients for the manufacture of a drug for therapies for chronic nephropathies and a method for conducting said screening.
La présente invention concerne lutilisation de WNT1 en tant que biomarqueur dans la surveillance, le pronostic et/ou le diagnostic de néphropathies chroniques. La présente invention concerne des procédés et des trousses de pronostic et de diagnostic in vitro pour sa mise en uvre. La présente invention concerne en outre lutilisation de WNT1 dans le criblage de principes actifs pour la fabrication dun médicament pour des thérapies pour des néphropathies chroniques et un procédé pour conduire ledit criblage.
Banon-Maneus Elisenda
Campistol Plana Josep Maria
Quintana Porras Luis Fernando
Fetherstonhaugh & Co.
Hospital Clinic I. Provincial de Barcelona
Institut de Investigacions Biomediques August Pi I. Sunyer
LandOfFree
Wnt1 as a renal damage biomarker does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Wnt1 as a renal damage biomarker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wnt1 as a renal damage biomarker will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1960220